These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25582500)

  • 1. Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas.
    Pennanen M; Heiskanen I; Sane T; Remes S; Mustonen H; Haglund C; Arola J
    Hum Pathol; 2015 Mar; 46(3):404-10. PubMed ID: 25582500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma.
    Duregon E; Cappellesso R; Maffeis V; Zaggia B; Ventura L; Berruti A; Terzolo M; Fassina A; Volante M; Papotti M
    Hum Pathol; 2017 Apr; 62():1-7. PubMed ID: 27916625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis.
    Yamazaki Y; Nakamura Y; Shibahara Y; Konosu-Fukaya S; Sato N; Kubota-Nakayama F; Oki Y; Baba S; Midorikawa S; Morimoto R; Satoh F; Sasano H
    Hum Pathol; 2016 Jul; 53():41-50. PubMed ID: 26980031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification.
    Volante M; Bollito E; Sperone P; Tavaglione V; Daffara F; Porpiglia F; Terzolo M; Berruti A; Papotti M
    Histopathology; 2009 Nov; 55(5):535-43. PubMed ID: 19912359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological study of adrenocortical carcinoma with special reference to the Weiss system and TNM staging and the role of immunohistochemistry to differentiate it from renal cell carcinoma.
    Mondal SK; Dasgupta S; Jain P; Mandal PK; Sinha SK
    J Cancer Res Ther; 2013; 9(3):436-41. PubMed ID: 24125979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis.
    Stojadinovic A; Brennan MF; Hoos A; Omeroglu A; Leung DH; Dudas ME; Nissan A; Cordon-Cardo C; Ghossein RA
    Mod Pathol; 2003 Aug; 16(8):742-51. PubMed ID: 12920217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors.
    Pinheiro C; Granja S; Longatto-Filho A; Faria AM; Fragoso MC; Lovisolo SM; Lerário AM; Almeida MQ; Baltazar F; Zerbini MC
    Oncotarget; 2015 Dec; 6(42):44403-21. PubMed ID: 26587828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases.
    Duregon E; Fassina A; Volante M; Nesi G; Santi R; Gatti G; Cappellesso R; Dalino Ciaramella P; Ventura L; Gambacorta M; Dei Tos AP; Loli P; Mannelli M; Mantero F; Berruti A; Terzolo M; Papotti M
    Am J Surg Pathol; 2013 Sep; 37(9):1433-40. PubMed ID: 23774167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma.
    Sasano H; Suzuki T; Moriya T
    Endocr Pathol; 2006; 17(4):345-54. PubMed ID: 17525483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma.
    Duregon E; Molinaro L; Volante M; Ventura L; Righi L; Bolla S; Terzolo M; Sapino A; Papotti MG
    Mod Pathol; 2014 Sep; 27(9):1246-54. PubMed ID: 24434900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weiss criteria in large adrenocortical tumors: a validation study.
    Jain M; Kapoor S; Mishra A; Gupta S; Agarwal A
    Indian J Pathol Microbiol; 2010; 53(2):222-6. PubMed ID: 20551521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Weiss system for evaluating adrenocortical neoplasms: 25 years later.
    Lau SK; Weiss LM
    Hum Pathol; 2009 Jun; 40(6):757-68. PubMed ID: 19442788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.
    Soon PS; Gill AJ; Benn DE; Clarkson A; Robinson BG; McDonald KL; Sidhu SB
    Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic criteria for adrenocortical proliferative lesions: value of mitotic figure variability.
    Blanes A; Diaz-Cano SJ
    Am J Clin Pathol; 2007 Mar; 127(3):398-408. PubMed ID: 17276949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of histological and immunohistochemical patterns of benign and malignant adrenocortical tumors by computerized morphometry.
    Dalino Ciaramella P; Vertemati M; Petrella D; Bonacina E; Grossrubatscher E; Duregon E; Volante M; Papotti M; Loli P
    Pathol Res Pract; 2017 Jul; 213(7):815-823. PubMed ID: 28554744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease.
    Asare EA; Wang TS; Winchester DP; Mallin K; Kebebew E; Sturgeon C
    Surgery; 2014 Dec; 156(6):1378-85; discussion 1385-6. PubMed ID: 25456914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Wnt and TGF-β pathway components and key adrenal transcription factors in adrenocortical tumors: association to carcinoma aggressiveness.
    Parviainen H; Schrade A; Kiiveri S; Prunskaite-Hyyryläinen R; Haglund C; Vainio S; Wilson DB; Arola J; Heikinheimo M
    Pathol Res Pract; 2013 Aug; 209(8):503-9. PubMed ID: 23866946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: Diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas.
    Volante M; Sperone P; Bollito E; Frangipane E; Rosas R; Daffara F; Terzolo M; Berruti A; Papotti M
    Mod Pathol; 2006 Dec; 19(12):1563-9. PubMed ID: 16980949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.
    Mete O; Erickson LA; Juhlin CC; de Krijger RR; Sasano H; Volante M; Papotti MG
    Endocr Pathol; 2022 Mar; 33(1):155-196. PubMed ID: 35288842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric Adrenocortical Neoplasms: A Study Comparing Three Histopathological Scoring Systems.
    Jangir H; Ahuja I; Agarwal S; Jain V; Meena JP; Agarwala S; Sharma R; Sharma MC; Iyer VK; Mani K
    Endocr Pathol; 2023 Jun; 34(2):213-223. PubMed ID: 37160532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.